133 related articles for article (PubMed ID: 11953279)
21. [The effect of hyperinflation on respiratory muscles and breathing pattern in COPD].
Akkoca O; Demir G; Saryal S; Karabiyikoğlu G
Tuberk Toraks; 2003; 51(3):244-52. PubMed ID: 15143401
[TBL] [Abstract][Full Text] [Related]
22. Effects of pneumoperitoneum and positioning on respiratory mechanics in chronic obstructive pulmonary disease patients during Nissen fundoplication.
Salihoglu Z; Demiroluk S; Baca B; Ayan F; Kara H
Surg Laparosc Endosc Percutan Tech; 2008 Oct; 18(5):437-40. PubMed ID: 18936660
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
24. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
25. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
[TBL] [Abstract][Full Text] [Related]
26. [Effect of dead space loading on ventilation, respiratory muscle and exercise performance in chronic obstructive pulmonary disease].
Zhao L; Lu JB; Yang SQ; Zhu LH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):748-51. PubMed ID: 15634386
[TBL] [Abstract][Full Text] [Related]
27. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
Brophy C; Kastelik J; Gardiner E; Greenstone M
Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
[TBL] [Abstract][Full Text] [Related]
29. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
Moretti M; Bottrighi P; Dallari R; Da Porto R; Dolcetti A; Grandi P; Garuti G; Guffanti E; Roversi P; De Gugliemo M; Potena A;
Drugs Exp Clin Res; 2004; 30(4):143-52. PubMed ID: 15553660
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study.
Ohbayashi H; Setoguchi Y; Fukuchi Y; Shibata K; Sakata Y; Arai T
Pulm Pharmacol Ther; 2016 Apr; 37():73-80. PubMed ID: 26952317
[TBL] [Abstract][Full Text] [Related]
31. [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
Kerstjens HA; Postma DS
Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1631-5. PubMed ID: 12233157
[TBL] [Abstract][Full Text] [Related]
32. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
[TBL] [Abstract][Full Text] [Related]
33. Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.
Koppitz M; Eschenburg C; Salzmann E; Rosewich M; Schubert R; Zielen S
PLoS One; 2016; 11(6):e0156999. PubMed ID: 27308826
[TBL] [Abstract][Full Text] [Related]
34. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
35. [The effect of the inhalation of a single atrovent dose on pulmonary ventilation function and respiratory mechanics in patients with chronic obstructive bronchitis].
Tetenev FF; Cherniavskaia GM
Ter Arkh; 1989; 61(8):53-5. PubMed ID: 2531477
[TBL] [Abstract][Full Text] [Related]
36. Effects of nebulized beta 2-adrenergic agonists on pulmonary mechanics in anesthetized patients with chronic obstructive pulmonary disease.
Vichitvejpaisal P; Joshi GP; Kumar S; White PF
J Med Assoc Thai; 1996 Dec; 79(12):779-84. PubMed ID: 9071082
[TBL] [Abstract][Full Text] [Related]
37. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
38. Action of a mucolytic in the first 72 hours after abdominal surgery. Concerning 34 patients with respiratory insufficiency.
Devaux C; Bagot C; Chouckroun J
Acta Anaesthesiol Belg; 1980; 31 Suppl():137-46. PubMed ID: 6779493
[No Abstract] [Full Text] [Related]
39. [Comparative clinical evaluation of two mucolytic agents: S-carboxy-methyl-cysteine and letosteine (author's transl)].
Blaive B; Lapalus P; Lemoigne F
Sem Hop; 1978 Oct 8-15; 54(29-32):983-6. PubMed ID: 216094
[TBL] [Abstract][Full Text] [Related]
40. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
